| Research progress on mechanism of palmitic acid hydroxy stearic accid in anti-metabolic inflammatory syndrome |
| Click here to download the full text |
| Citation of this paper:YU Zhong-yu1, GUO Jing-chun2, ZHOU Hou-guang1*.Research progress on mechanism of palmitic acid hydroxy stearic accid in anti-metabolic inflammatory syndrome[J].Chinese Journal of Clinical Medicine,2019,26(1):136-140 |
| Hits: 1840 |
| Download times: 1154 |
| Author Name | Affiliation | | YU Zhong-yu1, GUO Jing-chun2, ZHOU Hou-guang1* | 1. Department of Geriatrics, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
2.State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China |
|
| Abstract:The prevalence of metabolic inflammatory syndrome (MIS) in the elderly is high, and imbalance of glucose and lipid homeostasis and insulin resistance are common in these patients. The novel compound, branched fatty acid esters of hydroxy fatty acids (FAHFAs), has effects of enhancing insulin sensitivity and anti-inflammatory, among which the content of palmitic acid hydroxy stearic acid (PAHSA) is the highest. The level of PAHSA in vivo is primarily regulated by the carbohydrate response element binding protein (CHREBP), which exerts a biological effects via G protein coupled receptor 120 (GPR120). This review mainly describes the research progress on the mechanism of PAHSA in metabolic inflammatory syndrome. |
| keywords:palmitic acid hydroxy stearic acid metabolic inflammatory syndrome G protein coupled receptor 120 insulin resistance inflammation |
| HTML View Full Text View/Add Comment Download reader |
|
|
|